MEME #00070

AI found CTRL+Z (undo) for biological age

THE REAL NEWS: Insilico Medicine's AI-designed drug rentosertib: in a 12-week Phase 2a (42 IPF patients), all six proteomic aging clocks flagged younger predicted biological age o...

Published October 5, 2026 · AI · Science

#AI #LILMEME00070 #MemesISNews

Read the original caption

THE REAL NEWS: Insilico Medicine's AI-designed drug rentosertib: in a 12-week Phase 2a (42 IPF patients), all six proteomic aging clocks flagged younger predicted biological age on treatment. THE ABSURD: ALL SIX CLOCKS HIT REWIND. Six rival models, one direction - a consensus we can use. THE BREAKDOWN: ~3-4 years younger at peak (week 4, 30 mg twice daily) in 2,841 blood proteins - not birthdays. The paper can't yet split aging effects from a treated lung. THE UPSIDE: If healthy-volunteer trials confirm it, medicine gets a new scoreboard for aging. Source: Nature Biotechnology, 7 Sept 2026. More memes: MemesIsNews.com. Own 'the Moon': Lilmeme.fun.

The real news

The story, straight

Insilico Medicine's AI-designed drug rentosertib: in a 12-week Phase 2a trial of 42 IPF patients, all six proteomic aging clocks showed younger predicted biological age on treatment, peaking at about 3-4 years of difference at week 4 across 2,841 blood proteins.

The paper's own caveat: it can't yet separate the aging effect from the treated lung.

The absurd

Why this is ridiculous

Six rival aging clocks, all six hit rewind. It is the first time the instruments of measurement have all agreed to disagree with the calendar in the same direction.

The breakdown

How it breaks down

'Biological age' here is a statistical reading of thousands of proteins - a fingerprint, not a birthday. Six separate models all pointing to 'younger' is a rare consensus.

But the same paper admits the needle may be moving for two reasons at once: the lung got treated, and the age marker moved with it. Correlation at six clocks is still one question: which one caused which.

The upside

Why it could matter

If healthy-volunteer trials confirm the direction, medicine gets a new scoreboard for aging: progress measured in years, not anecdotes. That is the part worth watching - not this drug, but the clock it validated.

A working aging clock turns 'longevity' from a hope into an engineering problem with a number on it.